10x Genomics (TXG) Receives a Buy from Morgan Stanley
Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...
StockStory.org on MSN1d
Why 10x Genomics (TXG) Shares Are Falling Today
What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 8.5% in the pre-market session after the company ...
10x Genomics price target lowered to $12 from $14 at JPMorgan
JPMorgan analyst Rachel Vatnsdal lowered the firm’s price target on 10x Genomics (TXG) to $12 from $14 and keeps a Neutral rating on the shares ...
Earnings call transcript: 10X Genomics Q4 2024 misses EPS forecast, stock dips
X Genomics Inc . (NASDAQ:TXG) reported its Q4 2024 earnings, revealing a larger-than-expected loss per share and a decline in revenue compared to the previous year. The company posted an EPS of -$0.40 ...
aggieswire.usatoday3d
2026 4-star TE out of Fairburn (GA) has decommitted from Texas A&M
After committing back in November 2026 4-star TE Xavier Tiller has decommitted from the program and will look at other options.